NLS Pharmaceutics Ltd.(NASDAQ:NLSP) 
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, a...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.45
H 1.56
L 1.45
C 1.48
V 13,023
10EMA 1.48
20EMA 1.48
60EMA 1.48
120EMA 1.48
250EMA 1.48